The largest community of pharma leaders

EXUMA Biotechnology Expands Leadership Team with Appointment of Chief Medical Officer and Chief Financial Officer

SHANGHAI & WEST PALM BEACH, Fla.–(BUSINESS WIRE)–EXUMA Biotechnology, a clinical-stage biotechnology company discovering and developing CAR-T products for solid tumors and affiliate of F1 Oncology, Inc., announced today the expansion of its leadership team with the appointment of Wendy Li, M.D. as Chief Medical Officer and James Samuels as Chief Financial Officer. “It’s been a successful quarter for EXUMA with the positive announcement of interim results from two first-in-human solid tumor CA….

Recent Articles